Drug Cos. See Path To Legal Off-Label Marketing

Law360, New York (May 10, 2013, 7:07 PM EDT) -- The drug industry is using a Second Circuit ruling that blocked the U.S. Food and Drug Administration from prosecuting a salesman for promoting a drug for off-label uses to push the agency to adopt regulations that would allow for truthful off-label marketing, hoping the change would significantly boost drug sales.

The Pharmaceutical Research and Manufacturers of America, the major trade group for the name-brand drug industry, would like to see the FDA change its regulations to allow off-label promotion, as long as the information shared is...
To view the full article, register now.